Received: 21 February 2019
Accepted: 4 November 2019
First Online: 25 November 2019
Ethics approval and consent to participate
: The clinical study was approved by the Ethics Committee of Kanazawa University (approval number 2012-109). All animal experiments were performed in accordance with the Guidelines on the Care and Use of Laboratory Animals issued by Kanazawa University and were approved by the Ethical Committee for Animal Experiments of Kanazawa University (approval number 143267). All experimental methods were in accordance with Helsinki Declaration.
: All participants provided written informed consent for publication of study results of the collected biomaterials paired with anonymized information on clinical data.
: The authors declare that they have no competing interests.